Markus Wahrmann - Concepedia

Author

Markus Wahrmann

Medical University of Vienna ORCID

Also Known As

M Wahrmann, M. Wahrmann, Markus Wahrmann

Publications

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna University of Alberta The Metabolomics Innovation Centre University of Vienna Statistics Austria

About

Markus Wahrmann is an author at Medical University of Vienna specializing in medicine, immunology, and kidney transplant.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	429
2	Public Health	3	3	46
3	Education	1	1	22
4	Engineering	1	1	22
5	Biochemistry	1	1	34

Markus Wahrmann

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection Farsad Eskandary, Heinz Regele, Lukas Baumann, Journal of the American Society of Nephrology	2017	288
Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection Heinz Regele, Markus Exner, Bruno Watschinger, Nephrology Dialysis Transplantation	2001	234
A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection Konstantin Doberer, Michael Duerr, Philip F. Halloran, Journal of the American Society of Nephrology	2020	162
Immunoadsorption in Severe C4d-Positive Acute Kidney Allograft Rejection: A Randomized Controlled Trial GA Böhmig, Markus Wahrmann, Heinz Regele, American Journal of Transplantation	2006	140
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection Konstantin Doberer, Johannes Kläger, Guido A. Gualdoni, Transplantation	2020	110
Complement Component C3 Activation Elisabeth Schwaiger, Markus Wahrmann, Gregor Bond, Transplantation	2014	106
Posttransplant HLA Alloreactivity in Stable Kidney Transplant Recipients—Incidences and Impact on Long-Term Allograft Outcomes Gregor Bartel, Heinz Regele, Markus Wahrmann, American Journal of Transplantation Transplant RejectionUrologyTransplantationPosttransplant Hla AlloreactivityKidney Transplant	2008	82
Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection—results from a first-in-patient phase 1 trial Farsad Eskandary, Bernd Jilma, Jakob Mühlbacher, American Journal of Transplantation	2017	80
Peritransplant Immunoadsorption for Positive Crossmatch Deceased Donor Kidney Transplantation Gregor Bartel, Markus Wahrmann, Heinz Regele, American Journal of Transplantation	2010	76
Pivotal Role of Complement-Fixing HLA Alloantibodies in Presensitized Kidney Allograft Recipients Markus Wahrmann, Markus Exner, Martin Schillinger, American Journal of Transplantation HistocompatibilityComplement FixationImmunologyPathologyComplement-fixing Hla Presensitization	2006	69

Page 1